HAE vs XEL · P/E 35, rev $1.33B vs P/E 20, $39.33B cap
Haemonetics Corporation (HAE) versus Xcel Energy Inc (XEL) — a side-by-side from cached financials, not a winner call.
Haemonetics Corporation (HAE) is a medical devices company listed on US.
Xcel Energy Inc (XEL) is a utilities - regulated electric company listed on US.
Latest reported HAE revenue for 2026-03-28 was $1.33B. Net income was $97.3M. Revenue was down 2.0% from 2025-03-29 to 2026-03-28. HAE currently screens at market cap $3.24B and trailing P/E 34.8.
XEL does not have a complete income-statement cache yet.
HAE currently screens at market cap $3.24B and trailing P/E 34.8. XEL currently screens at market cap $39.33B and trailing P/E 20.1.
Not investment advice. Open the HAE and XEL stock pages for the full models.
Not investment advice.